Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION (Details)

v3.25.1
SEGMENT INFORMATION (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Total revenues $ 53,333 $ 29,534
Less:    
Cost of product sales 4,409 2,025
Provision for income taxes 65 0
Net income (loss) 11,446 (8,247)
Single reportable segment    
Segment Reporting Information [Line Items]    
Total revenues 53,333 29,534
Less:    
Employee related expenses 19,538 19,367
Commercial related expenses 5,339 5,109
Outside clinical trial related expenses 4,371 2,512
Cost of product sales 4,409 2,025
Consultants and third-party services 3,409 4,343
Other segment items 3,494 3,144
Interest expense, net 1,262 1,281
Provision for income taxes 65  
Net income (loss) $ 11,446 $ (8,247)